Novartis Japan Looks To Capitalize On Drug Approval Spurt, Submits NDA For Everolimus

Novartis Japanese subsidiary Novartis Pharma KK announced Jan. 21 four new drug approvals from Japan's Ministry of Health, Labor and Welfare. The new drugs are approved to treat asthma, hypertension, cancer and age-related macular degeneration